Physician

Salvatore Quinto Napoli, M.D.

According to 2025 Medicare claims, Salvatore Napoli, M.D. (NPI: 1588715882) practices neurology in the Boston, MA market, with the plurality of this provider's patient population coming from Norfolk, MA. This provider's primary affiliated billing organization is NEUROLOGY CENTER OF NEW ENGLAND, P.C. (NPI: 1679817027; TIN: 461420654) and primary practice location at 02035-1462.

Napoli's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 430 traditional Medicare patients, billed 426,521 HCPCS/CPT codes, and received $5,027,250 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,501 prescription claims across 243 beneficiaries totaling $4,060,958 in drug costs, led by Kesimpta Pen (Ofatumumab). 2023 DME data shows 11 claims. Open Payments data shows 288 records totaling $496,846. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $336,667 to $5,027,250. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $2,798 to $5,942.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	466	10,588	$336,667
2016	464	20,253	$321,411
2017	507	15,453	$317,266
2018	654	33,547	$1,006,863
2019	622	61,018	$1,435,190
2020	568	68,723	$1,587,430
2021	315	49,168	$2,189,191
2022	336	51,627	$1,548,530
2023	413	115,478	$3,336,501
2024	430	426,521	$5,027,250

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	221	2,142	$4,301,671
2016	228	2,177	$4,165,979
2017	244	2,706	$4,902,369
2018	326	3,347	$7,023,510
2019	306	2,947	$6,078,613
2020	288	2,640	$6,609,149
2021	269	2,592	$6,768,977
2022	296	3,087	$8,325,711
2023	306	2,793	$6,948,526
2024	243	1,501	$4,060,958

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	11	$115
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	110	141	$114
96413	Administration of chemotherapy into vein, 1 hour or less	102	507	$105
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	132	211	$92
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	68	362	$51
96415	Administration of chemotherapy into vein, each additional hour	54	211	$20

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Kesimpta Pen	Ofatumumab	81	2,405	$713,129
Aubagio	Teriflunomide	59	2,130	$648,554
Ocrevus	Ocrelizumab	12	1,840	$470,511
Copaxone	Glatiramer Acetate	52	1,512	$288,515
Tysabri	Natalizumab	34	952	$283,992

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	198	$86,186	TG Therapeutics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	90	$410,660	TG Therapeutics, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Salvatore Quinto Napoli, M.D.?

Tedicare shows public-source Medicare data for Salvatore Quinto Napoli, M.D. (NPI 1588715882), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Salvatore Quinto Napoli, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Salvatore Quinto Napoli, M.D.?

Salvatore Quinto Napoli, M.D. is linked to NEUROLOGY CENTER OF NEW ENGLAND, P.C. (billing NPI 1679817027) in the available physician profile data.

Does Salvatore Quinto Napoli, M.D. have Open Payments data?

Salvatore Quinto Napoli, M.D. has 288 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.